Position in ONC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,139
-$48 QoQ
Shares Held
4
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#271
of 282 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nemes Rush Group LLC holds $3,327,523 across 17 Biotechnology names. ONC ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,579 | $2,771,256 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
5,165 | $201,486 | |
| 3 | SLS |
SELLAS Life Sciences Group, Inc.
|
10,000 | $147,600 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
2,000 | $109,880 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
2,000 | $50,600 | |
| 6 | DNLI |
Denali Therapeutics Inc.
|
700 | $18,004 | |
| 7 | CRMD |
CorMedix Inc.
|
2,000 | $15,700 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8 | $4,988 |
All Filings in ONC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,139 | 4 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,187 | 4 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,215 | 4 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||